New pill shows promise for Long-Term ulcerative colitis control
NCT ID NCT05177835
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests the long-term safety and effectiveness of an experimental drug called ABX464 in people with moderate to severe ulcerative colitis. Participants who previously improved on ABX464 in earlier studies will continue taking it daily for up to 54 months. Researchers will track side effects and how many patients stay in remission over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ABX464 (an experimental oral drug)
What this could lead to
If successful, this could provide a long-term treatment option for people with moderate to severe ulcerative colitis, helping maintain remission.
What could go wrong
This is an early-phase, open-label study with no placebo group, so results may be less reliable. Long-term safety is still being evaluated, and the drug may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Antwerp University Hospital
Antwerp, Belgium
-
CHU Nantes - Hôtel Dieu
Nantes, France
-
CHU Saint Etienne - Hôpital Nord
Saint-Etienne, France
-
Centre Hospitalier Universitaire De Montpellier
Montpellier, France
-
Centre Hospitalier Universitaire Grenoble Alpes
Grenoble, France
-
Centro Medico Teknon
Barcelona, Spain
-
Centrum Badan Klinicznych Piotr Napora Lekarze Spolka Partnerska
Wroclaw, Poland
-
Centrum Medyczne Oporow
Wroclaw, Poland
-
Centrum Medyczne Plejady
Krakow, Poland
-
Cliniq s.r.o.
Bratislava, Slovakia
-
Communal non-commercial enterprise "Cherkasy Regional Hospital of Cherkasy regional council"
Cherkasy, Ukraine
-
Communal non-commercial enterprise "Khmelnytska Regional Hospital" of Khmelnytskiy regional council
Khmelnytskyi, Ukraine
-
DRC Gyogyszervizsgalo Kozpont Kft.
Balatonfüred, Hungary
-
Endomed s.r.o
Vranov nad Topľou, Slovakia
-
Fakultni nemocnice u sv. Anny v Brne
Brno, Czechia
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Italy
-
GASTRO I, s.r.o.
Prešov, Slovakia
-
Goethe University Frankfurt
Frankfurt, Germany
-
Győr-Moson-Sopron Vármegyei Petz Aladár Egyetemi Oktató Kórház I. Belgyógyászat
Győr, Hungary
-
Humanitas Mirasole S.p.A.
Rozzano, Italy
-
IRCCS Ospedale Sacro Cuore Don Calabria
Verona, Italy
-
Institut des MICI
Neuilly-sur-Seine, France
-
Kliničko bolnički centar Zvezdara
Belgrade, Serbia
-
LexMedica
Wroclaw, Poland
-
Medical Network Sp. z o.o.
Warsaw, Poland
-
Medical University of Vienna
Vienna, Austria
-
Medicome Sp. z o. o.
Oświęcim, Poland
-
Medizinische Hochschule Hannover
Hanover, Germany
-
Medizinische Universitaet Innsbruck
Innsbruck, Austria
-
Nemocnice Slany
Slaný, Czechia
-
Niepubliczny Zaklad Opieki Zdrowotnej Neuromed M. i M. Nastaj sp. p
Lublin, Poland
-
Opšta bolnica "Đorđe Joanović" Zrenjanin Odsek za gastroenterologiju
Zrenjanin, Serbia
-
Ośrodek Badań Klinicznych "METABOLICA"
Tarnów, Poland
-
Samodzielny PZOZ w Lecznej
Łęczna, 21-010, Poland
-
Santa Sp. z o.o.
Warsaw, Poland
-
Semmelweis University
Budapest, Hungary
-
South Edmonton Gastroenterology
Edmonton, Canada
-
Splosna Bolnisnica Murska Sobota
Murska Sobota, Slovenia
-
Splošna bolnišnica Celje
Celje, Slovenia
-
Studiengesellschaft BSF UG (haftungsbeschraenkt)
Halle, Germany
-
Termedia Sp. z o.o (NSZOZ Termedica - Centrum Badan Klinicznych)
Poznan, Poland
-
Trialmed CRS
Piotrkow Trybunalski, Poland
-
UZ Leuven
Leuven, Belgium
-
Univerzitetni klinični center Maribor
Maribor, Slovenia
-
Vasutegeszseguegyi Nonprofit Koezhasznu Kft.
Debrecen, Hungary
-
Wojskowy Szpital Kliniczny w Lublinie
Lublin, Poland